[HTML][HTML] Biomarkers during COVID-19: mechanisms of change and implications for patient outcomes
As the COVID-19 (Coronavirus disease 19) pandemic spreads worldwide, the massive
numbers of COVID-19 patients have created a considerable healthcare burden for every …
numbers of COVID-19 patients have created a considerable healthcare burden for every …
[HTML][HTML] Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis
K Noonong, M Chatatikun, S Surinkaew… - Frontiers in …, 2023 - frontiersin.org
Significance This review discusses the coronavirus disease 2019 (COVID-19)
pathophysiology in the context of diabetes and intracellular reactions by COVID-19 …
pathophysiology in the context of diabetes and intracellular reactions by COVID-19 …
Early prediction of COVID-19 outcome using artificial intelligence techniques and only five laboratory indices
We aimed to develop a prediction model for intensive care unit (ICU) hospitalization of
Coronavirus disease-19 (COVID-19) patients using artificial neural networks (ANN). We …
Coronavirus disease-19 (COVID-19) patients using artificial neural networks (ANN). We …
Increased incidence of rhino‐orbital mucormycosis in an educational therapeutic hospital during the COVID‐19 pandemic in western Iran: an observational study
M Avatef Fazeli, L Rezaei, E Javadirad, K Iranfar… - Mycoses, 2021 - Wiley Online Library
Background COVID‐19 patients, especially the patients requiring hospitalisation, have a
high risk of several complications such as opportunistic bacterial and fungal infections …
high risk of several complications such as opportunistic bacterial and fungal infections …
[HTML][HTML] Herpes simplex virus re-activation in patients with SARS-CoV-2 pneumonia: a prospective, observational study
E Franceschini, A Cozzi-Lepri, A Santoro, E Bacca… - Microorganisms, 2021 - mdpi.com
Background: Herpes simplex 1 co-infections in patients with COVID-19 are considered
relatively uncommon; some reports on re-activations in patients in intensive-care units were …
relatively uncommon; some reports on re-activations in patients in intensive-care units were …
[HTML][HTML] Clinical characteristics and mortality associated with COVID-19 at high altitude: a cohort of 5161 patients in Bogotá, Colombia
DR Rodriguez Lima, ÁM Pinzón Rondón… - International Journal of …, 2022 - Springer
Background There are few data on the clinical outcomes of patients with coronavirus
disease 2019 (COVID-19) in cities over 1000 m above sea level (masl). Objectives To …
disease 2019 (COVID-19) in cities over 1000 m above sea level (masl). Objectives To …
Prognostic parameters of in‐hospital mortality in COVID‐19 patients—An Italian experience
M Ruscica, C Macchi, S Iodice… - European journal of …, 2021 - Wiley Online Library
Abstract Background During COVID‐19 outbreak, Italy was the first country in Europe to be
heavily affected with an intensive care unit mortality of 26%. In order to reduce this …
heavily affected with an intensive care unit mortality of 26%. In order to reduce this …
CRP, SAA, LDH, and DD predict poor prognosis of coronavirus disease (COVID-19): a meta-analysis from 7739 patients
L Wang, LM Yang, SF Pei, YZ Chong… - … Journal of Clinical …, 2021 - Taylor & Francis
Understanding factors associated with disease severity and mortality from coronavirus
disease (COVID-19) was critical for effective risk stratification. We aimed to investigate the …
disease (COVID-19) was critical for effective risk stratification. We aimed to investigate the …
[HTML][HTML] Increased lactate dehydrogenase reflects the progression of COVID-19 pneumonia on chest computed tomography and predicts subsequent severe disease
K Kojima, H Yoon, K Okishio, K Tsuyuguchi - Scientific Reports, 2023 - nature.com
Chest computed tomography (CT) is effective for assessing the severity of coronavirus
disease 2019 (COVID-19). However, the clinical factors reflecting the disease progression of …
disease 2019 (COVID-19). However, the clinical factors reflecting the disease progression of …
Dipeptidyl peptidase-4 (DPP-IV) inhibitor was associated with mortality reduction in COVID-19—A systematic review and meta-analysis
AFMZ Zein, WM Raffaello - Primary care diabetes, 2022 - Elsevier
Introduction This systematic review and meta-analysis aimed to synthesize the latest
evidence on the effect of dipeptidyl peptidase-4 (DPP-IV) inhibitor in patients with COVID-19 …
evidence on the effect of dipeptidyl peptidase-4 (DPP-IV) inhibitor in patients with COVID-19 …